A federal watchdog will take on Medicare scams; Belviq, a weight loss drug, has been pulled from market; issues at Veterans Affairs have resulted in healthcare roadblocks.
A federal government watchdog is planning to conduct a nationwide probe into telemarketers’ attaining of personal Medicare information, the Associated Press reports. The audit is expected to be announced next week and will aim to crack down on potential fraud and waste. Telemarketing scams targeting Medicare recipients have been on the rise, with impersonators posing as a pharmacy or doctor’s office to elicit information. According to the AP, personal details are gleaned from Medicare files and can then be cross-referenced with databases of phone numbers or other contact information. Healthcare fraud costs taxpayers tens of billions of dollars a year, the AP reports.
Eisai Inc, a Japanese company, has pulled the weight loss drug Belviq from the market after federal regulators said it posed a small increased risk of cancer, The Washington Post reports. The company, however, said it disagreed with the FDA’s interpretation of new safety data released on the drug. In an FDA analysis, researchers found 7.7% of users were diagnosed with cancer compared with slightly more than 7.1% of a control group. The drug was approved in 2012 and was the first drug meant to help people lose weight, without increasing the risk for heart problems.
Veterans Affairs, the agency that oversees care for over 9 million former service members, has recently run into roadblocks hindering their progress, The New York Times reports. In addition to the recent firing of the deparment's deputy secretary, efforts to overhaul the system have been met with implementation issues. The Mission Act, part of the Trump administration's aim to expand care outside of the department's health facilities, has not received the funding necessary for coverage goals. An overhaul of veterans' medical records, estimated to cost $16 billion, has also been delayed due to technical issues. In his most recent budget proposal, President Trump proposed a 10% increase to the department's budget, raising it to $243 billion.
What's at Stake as Oral Arguments Are Presented in the Braidwood Case? Q&A With Richard Hughes IV
April 21st 2025Richard Hughes IV, JD, MPH, spoke about the upcoming oral arguments to be presented to the Supreme Court regarding the Braidwood case, which would determine how preventive services are guaranteed insurance coverage.
Read More
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
Comparing Breast Cancer Treatment Outcomes Between Fee-for-Service and Medicare Advantage
April 4th 2025This study examined postdiagnosis breast cancer treatment outcomes for Medicare Advantage vs fee-for-service (FFS) Medicare in Ohio and found no significant differences overall but disparities for Black patients with FFS Medicare.
Read More